H1N1v Virus Challenge Study in Healthy Subjects

计划入组 76 人 · 首次发布于 2019 年 8 月 5 日

Active Surveillance for Bethesda IV Thyroid Nodules

计划入组 165 人 · 首次发布于 2026 年 1 月 27 日

Non-specific Response to H1N1 Vaccine

计划入组 14 人 · 首次发布于 2010 年 8 月 10 日

Influenza A/Bethesda/MM2/H1N1 Challenge (NIAID)

H1N1 influenza vaccine

Influenza virus type A (H1N1)(FluMist Quadrivalent)

Evangelisches Krankenhaus Bethesda

Germany

Baptist Health South Florida Foundation, Inc.

United States

United States Department of The Navy

United States

NIH Launches Influenza Human Challenge Study to Advance Vaccine Development

Mangoceuticals Advances H1N1 Study and Expands Research to H5N1 Influenza

CYP-006TK Shows Promise in Phase 1 Trial for Diabetic Foot Ulcers